Haitham Sahawneh

Ocular immune-related adverse events with immune checkpoint inhibitors: A retrospective cohort study

Background Immune checkpoint inhibitors (ICIs) are widely used to treat a variety of malignancies. Ocular immune-related adverse events (irAEs) have been increasingly recognized as rare side effects of these medications. Methods We performed a retrospective study of ocular irAEs...